Literature DB >> 31810915

6-Hydroxythiobinupharidine Inhibits Migration of LM8 Osteosarcoma Cells by Decreasing Expression of LIM Domain Kinase 1.

Masato Yoshizawa1, Seikou Nakamura2, Yuki Sugiyama1, Shiori Tamai1, Yukiko Ishida1, Mari Sueyoshi1, Yuki Toda1, Shigekuni Hosogi1, Yoshitaka Yano3, Eishi Ashihara4.   

Abstract

BACKGROUND/AIM: Osteosarcoma is the most malignant type of bone tumor. Patients with osteosarcoma metastases have a poorer prognosis than those without metastases. Thus, the prognosis of osteosarcoma patients with metastases must be improved.
MATERIALS AND METHODS: The present study investigated the inhibitory effects of 6-hydroxythiobinupharidine isolated from Nuphar pumilum on migration of LM8 murine osteosarcoma cells by a migration assay and also examined the expression of proteins related to actin dynamics by western blot. The present study also developed an automatic cell counting system using machine learning to count migrated cells by Fiji and Trainable Weka Segmentation.
RESULTS: 6-Hydroxythiobinupharidine inhibited migration of LM8 osteosarcoma cells in a dose-dependent manner, and decreased protein expression of Lin11, Isl-1, and Mec-3 domain kinase 1 (LIMK1) and the levels of phosphorylated Cofilin.
CONCLUSION: 6-Hydroxythiobinupharidine suppressed migration of LM8 osteosarcoma cells by decreasing expression of LIMK1. 6-Hydroxythiobinupharidine could be potentially used as an anti-metastatic compound. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  6-hydroxythiobinupharidine; Cofilin; LIMK; Osteosarcoma; machine learning; metastasis

Year:  2019        PMID: 31810915     DOI: 10.21873/anticanres.13865

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  LncRNA TDRG1 Promotes Proliferation, Invasion and Epithelial-Mesenchymal Transformation of Osteosarcoma Through PI3K/AKT Signal Pathway.

Authors:  Yan Huang; Yong-Qiang Xu; Si-Yin Feng; Xiang Zhang; Jiang-Dong Ni
Journal:  Cancer Manag Res       Date:  2020-06-15       Impact factor: 3.989

2.  TRIP6 regulates the proliferation, migration, invasion and apoptosis of osteosarcoma cells by activating the NF-κB signaling pathway.

Authors:  Wei Liu; Li Cheng; Qingning Li; Juehua Jing
Journal:  Exp Ther Med       Date:  2020-01-22       Impact factor: 2.447

Review 3.  LIM Kinases in Osteosarcoma Development.

Authors:  Régis Brion; Laura Regnier; Mathilde Mullard; Jérome Amiaud; Françoise Rédini; Franck Verrecchia
Journal:  Cells       Date:  2021-12-15       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.